MAIA Biotechnology
MAIA
MAIA
20 hedge funds and large institutions have $1.5M invested in MAIA Biotechnology in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$237K | |
| 2 | +$71K | |
| 3 | +$55.1K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$19.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.56K |
Top Sellers
| 1 | -$204K | |
| 2 | -$153K | |
| 3 | -$74.2K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$66K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$28K |